Jubilant Life Sciences has reported results for first quarter ended June 30, 2018.
The company has reported a rise of 7.13% in net profit at Rs 23.88 crore for the quarter under review as compared to net profit of Rs 22.29 crore for the same quarter in the previous year. Total income of the company increased by 15.26% at Rs 831.05 crore for Q1FY19 as compared Rs 721.02 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 37.62% in its net profit at Rs 202.50 crore for the quarter under review as compared to Rs 147.14 crore for the same quarter in the previous year. Total consolidated income of the company increased by 30.27% at Rs 2,088.12 crore for Q1FY19 as compared Rs 1,602.86 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.50 |
Dr. Reddys Lab | 5784.50 |
Cipla | 1451.25 |
Zydus Lifesciences | 1001.15 |
Lupin | 1587.90 |
View more.. |